Prestige Consumer Healthcare Plans Upcoming Earnings Release
Prestige Consumer Healthcare Inc. (NYSE: PBH), known for its extensive range of consumer healthcare products, is gearing up to share its third quarter earnings for fiscal 2025. On a determined path, the company has announced its earnings release will be set for an early morning announcement on a Thursday in February. As investors eagerly await the results, the company extends an invitation to join the discussion during a conference call scheduled on the same day at 8:30 a.m. ET.
Joining the Earnings Call
Participating in the conference call is straightforward. Interested parties can access the live Internet webcast through the Investor Relations page of Prestige Consumer Healthcare’s official website. While there’s no requirement to register, it’s suggested that participants log in at least 10 minutes prior to the start of the call to ensure a seamless experience. For those who prefer joining via phone, registration is available online to secure dial-in details and a unique PIN.
Replay of the Conference Call
For those unable to join the call live, a replay will be accessible on the Investor Relations page for one week after the event. This makes it convenient for stakeholders to stay informed on the company’s performance and developments.
Highlighting the ICR Conference
In addition to the earnings announcement, Prestige Consumer Healthcare is also participating in the annual ICR Conference. Taking place in Orlando, the company will engage in a fireside chat scheduled for mid-January. This event is another opportunity for the firm to connect with investors and media, sharing insights about their strategic initiatives and brand offerings.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading player in the consumer healthcare market, operating across multiple countries, including the U.S., Canada, and Australia. The company’s diverse portfolio features well-recognized brands such as Monistat and Summer's Eve, targeting women’s health. Additionally, it provides a range of pain relievers under the BC and Goody's names, as well as eye care products like Clear Eyes and TheraTears.
Moreover, other notable offerings include DenTek specialty oral care products, Dramamine treatments for motion sickness, and Fleet enemas. The company also markets sore throat treatments like Chloraseptic, wart treatments via Compound W, and pediatric products under the Little Remedies brand. For diaper rash, parents can turn to Boudreaux’s Butt Paste, while lice treatment is efficiently managed with Nix. The company's reputation is further enhanced with effective earwax removal solutions from Debrox and antacid products like Gaviscon in Canada, along with Hydralyte rehydration solutions and Fess nasal care products in Australia.
Investor Relations Contact Information
For more detailed information or inquiries, investors can reach out directly to Phil Terpolilli, CFA, at 914-524-6819. Additionally, any questions can be directed via email for a prompt response regarding any investor-related matters.
Frequently Asked Questions
What is the earnings release date for Prestige Consumer Healthcare?
The earnings release date is set for February 6, 2025.
How can I participate in the conference call?
Participants can join via Internet webcast on the company’s Investor Relations page or register for phone access to receive details.
Will the conference call be available for replay?
Yes, a replay of the conference call will be available for approximately one week afterwards.
What brands does Prestige Consumer Healthcare offer?
Prestige markets a variety of brands, including Monistat, Summer's Eve, and many more across different healthcare categories.
Who can I contact for more information?
For further inquiries, you can contact Phil Terpolilli at 914-524-6819 or send an email to their Investor Relations department.
